JP5767103B2 - 夜間頻尿によって妨げられない睡眠の初期期間を増加させるための口腔内崩壊デスモプレシン - Google Patents

夜間頻尿によって妨げられない睡眠の初期期間を増加させるための口腔内崩壊デスモプレシン Download PDF

Info

Publication number
JP5767103B2
JP5767103B2 JP2011510705A JP2011510705A JP5767103B2 JP 5767103 B2 JP5767103 B2 JP 5767103B2 JP 2011510705 A JP2011510705 A JP 2011510705A JP 2011510705 A JP2011510705 A JP 2011510705A JP 5767103 B2 JP5767103 B2 JP 5767103B2
Authority
JP
Japan
Prior art keywords
pharmaceutical composition
desmopressin
dose
composition according
patient
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Active
Application number
JP2011510705A
Other languages
English (en)
Japanese (ja)
Other versions
JP2011520980A5 (enExample
JP2011520980A (ja
Inventor
クライン，ビャルケ，ミルナー
ノーガード，ジェンス，ペーター
シュメル，ブラッド
Original Assignee
フエリング・インターナシヨナル・センター・エス・アー
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=41100519&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=JP5767103(B2) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by フエリング・インターナシヨナル・センター・エス・アー filed Critical フエリング・インターナシヨナル・センター・エス・アー
Publication of JP2011520980A publication Critical patent/JP2011520980A/ja
Publication of JP2011520980A5 publication Critical patent/JP2011520980A5/ja
Application granted granted Critical
Publication of JP5767103B2 publication Critical patent/JP5767103B2/ja
Active legal-status Critical Current
Anticipated expiration legal-status Critical

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/04—Peptides having up to 20 amino acids in a fully defined sequence; Derivatives thereof
    • A61K38/08—Peptides having 5 to 11 amino acids
    • A61K38/095—Oxytocins; Vasopressins; Related peptides
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P13/00—Drugs for disorders of the urinary system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P13/00—Drugs for disorders of the urinary system
    • A61P13/02—Drugs for disorders of the urinary system of urine or of the urinary tract, e.g. urine acidifiers
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P13/00—Drugs for disorders of the urinary system
    • A61P13/10—Drugs for disorders of the urinary system of the bladder
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/20—Hypnotics; Sedatives
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P5/00—Drugs for disorders of the endocrine system
    • A61P5/10—Drugs for disorders of the endocrine system of the posterior pituitary hormones, e.g. oxytocin, ADH

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Chemical & Material Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Organic Chemistry (AREA)
  • Urology & Nephrology (AREA)
  • Epidemiology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Immunology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Diabetes (AREA)
  • Neurosurgery (AREA)
  • Neurology (AREA)
  • Biomedical Technology (AREA)
  • Anesthesiology (AREA)
  • Endocrinology (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Steroid Compounds (AREA)
  • Medicines Containing Plant Substances (AREA)
JP2011510705A 2008-05-21 2009-05-21 夜間頻尿によって妨げられない睡眠の初期期間を増加させるための口腔内崩壊デスモプレシン Active JP5767103B2 (ja)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US5512008P 2008-05-21 2008-05-21
US61/055,120 2008-05-21
PCT/US2009/044860 WO2009143356A1 (en) 2008-05-21 2009-05-21 Orodispersible desmopressin for increasing initial period of sleep undisturbed by nocturia

Related Child Applications (1)

Application Number Title Priority Date Filing Date
JP2015072698A Division JP6001121B2 (ja) 2008-05-21 2015-03-31 夜間頻尿によって妨げられない睡眠の初期期間を増加させるための口腔内崩壊デスモプレシン

Publications (3)

Publication Number Publication Date
JP2011520980A JP2011520980A (ja) 2011-07-21
JP2011520980A5 JP2011520980A5 (enExample) 2012-10-11
JP5767103B2 true JP5767103B2 (ja) 2015-08-19

Family

ID=41100519

Family Applications (5)

Application Number Title Priority Date Filing Date
JP2011510705A Active JP5767103B2 (ja) 2008-05-21 2009-05-21 夜間頻尿によって妨げられない睡眠の初期期間を増加させるための口腔内崩壊デスモプレシン
JP2015072698A Active JP6001121B2 (ja) 2008-05-21 2015-03-31 夜間頻尿によって妨げられない睡眠の初期期間を増加させるための口腔内崩壊デスモプレシン
JP2016169163A Active JP6258424B2 (ja) 2008-05-21 2016-08-31 夜間頻尿によって妨げられない睡眠の初期期間を増加させるための口腔内崩壊デスモプレシン
JP2017234382A Active JP6506821B2 (ja) 2008-05-21 2017-12-06 夜間頻尿によって妨げられない睡眠の初期期間を増加させるための口腔内崩壊デスモプレシン
JP2019067813A Active JP6836618B2 (ja) 2008-05-21 2019-03-29 夜間頻尿によって妨げられない睡眠の初期期間を増加させるための口腔内崩壊デスモプレシン

Family Applications After (4)

Application Number Title Priority Date Filing Date
JP2015072698A Active JP6001121B2 (ja) 2008-05-21 2015-03-31 夜間頻尿によって妨げられない睡眠の初期期間を増加させるための口腔内崩壊デスモプレシン
JP2016169163A Active JP6258424B2 (ja) 2008-05-21 2016-08-31 夜間頻尿によって妨げられない睡眠の初期期間を増加させるための口腔内崩壊デスモプレシン
JP2017234382A Active JP6506821B2 (ja) 2008-05-21 2017-12-06 夜間頻尿によって妨げられない睡眠の初期期間を増加させるための口腔内崩壊デスモプレシン
JP2019067813A Active JP6836618B2 (ja) 2008-05-21 2019-03-29 夜間頻尿によって妨げられない睡眠の初期期間を増加させるための口腔内崩壊デスモプレシン

Country Status (16)

Country Link
US (2) US9974826B2 (enExample)
EP (5) EP3085381B1 (enExample)
JP (5) JP5767103B2 (enExample)
CA (1) CA2724653A1 (enExample)
DK (5) DK3085381T3 (enExample)
ES (5) ES2710454T3 (enExample)
HR (4) HRP20161066T1 (enExample)
HU (5) HUE039013T4 (enExample)
LT (5) LT3225250T (enExample)
LU (1) LUC00015I2 (enExample)
NO (3) NO3085381T3 (enExample)
PL (5) PL3085381T3 (enExample)
PT (5) PT3225250T (enExample)
SI (4) SI3085381T1 (enExample)
TR (2) TR201807224T4 (enExample)
WO (1) WO2009143356A1 (enExample)

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2016196514A (ja) * 2008-05-21 2016-11-24 フエリング・インターナシヨナル・センター・エス・アー 夜間頻尿によって妨げられない睡眠の初期期間を増加させるための口腔内崩壊デスモプレシン

Families Citing this family (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US11963995B2 (en) 2008-05-21 2024-04-23 Ferring B.V. Methods comprising desmopressin
US20100286045A1 (en) 2008-05-21 2010-11-11 Bjarke Mirner Klein Methods comprising desmopressin
WO2015063602A1 (en) * 2013-10-29 2015-05-07 Ferring B.V. Desmopressin and blood glucose
US20210369654A1 (en) * 2018-10-16 2021-12-02 Nippon Chemiphar Co., Ltd. Agent for improving quality of sleep
JP7482033B2 (ja) * 2018-10-17 2024-05-13 日本ケミファ株式会社 夜間多尿の治療又は予防剤
CA3175207A1 (en) * 2020-04-14 2021-10-21 Satomi Yamasaki Sleep quality improver
WO2022103639A1 (en) 2020-11-16 2022-05-19 Orcosa Inc. Methods of treating autoimmune or inflammatory conditions with cannabidiol or its derivatives/analogs
US11672761B2 (en) 2020-11-16 2023-06-13 Orcosa Inc. Rapidly infusing platform and compositions for therapeutic treatment in humans

Family Cites Families (147)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CH495957A (de) 1966-09-15 1970-09-15 Ceskoslovenska Akademie Ved Verfahren zur Herstellung eines antidiuretisch wirksamen Polypeptids
US4316893A (en) * 1975-06-19 1982-02-23 Nelson Research & Development Co. Vehicle composition containing 1-substituted azacycloalkan-2-ones
US3989816A (en) 1975-06-19 1976-11-02 Nelson Research & Development Company Vehicle composition containing 1-substituted azacycloheptan-2-ones
US4405616A (en) 1975-06-19 1983-09-20 Nelson Research & Development Company Penetration enhancers for transdermal drug delivery of systemic agents
GB1548022A (en) 1976-10-06 1979-07-04 Wyeth John & Brother Ltd Pharmaceutial dosage forms
US4285858A (en) * 1979-10-30 1981-08-25 Mt. Sinai School Of Medicine Of The City University Of N.Y. Vasopressin analogs
US4263283A (en) * 1980-05-16 1981-04-21 Ferring Pharmaceuticals, Inc. Method for prophylaxis and/or treatment of sickle cell disease
GB2111423B (en) 1981-12-02 1985-06-26 Wyeth John & Brother Ltd Making quick-dissolving pills
DE3275121D1 (en) 1981-12-11 1987-02-19 Wyeth John & Brother Ltd Process for preparing solid shaped articles
US4557934A (en) 1983-06-21 1985-12-10 The Procter & Gamble Company Penetrating topical pharmaceutical compositions containing 1-dodecyl-azacycloheptan-2-one
SE8306367L (sv) 1983-11-18 1985-05-19 Ferring Ab Antidiuretiskt verkande farmaceutiskt preparat
US4863737A (en) 1985-05-01 1989-09-05 University Of Utah Compositions and methods of manufacture of compressed powder medicaments
US4588580B2 (en) * 1984-07-23 1999-02-16 Alaz Corp Transdermal administration of fentanyl and device therefor
IE60941B1 (en) * 1986-07-10 1994-09-07 Elan Transdermal Ltd Transdermal drug delivery device
US4878892A (en) 1987-02-10 1989-11-07 Drug Delivery Systems Inc. Electrolytic transdermal delivery of polypeptides
US4783450A (en) 1987-04-13 1988-11-08 Warner-Lambert Company Use of commercial lecithin as skin penetration enhancer
DK365389D0 (da) 1989-07-24 1989-07-24 Fertin Lab As Antifungalt tyggegummipraeparat
US5091186A (en) * 1989-08-15 1992-02-25 Cygnus Therapeutic Systems Biphasic transdermal drug delivery device
US5527288A (en) * 1990-12-13 1996-06-18 Elan Medical Technologies Limited Intradermal drug delivery device and method for intradermal delivery of drugs
TW279133B (enExample) 1990-12-13 1996-06-21 Elan Med Tech
SE9101022D0 (sv) * 1991-01-09 1991-04-08 Paal Svedman Medicinsk suganordning
US6746678B1 (en) * 1991-02-22 2004-06-08 Howard K. Shapiro Method of treating neurological diseases and etiologically related symptomology using carbonyl trapping agents in combination with medicaments
CA2070061C (en) 1991-06-07 2004-02-10 Shigeyuki Takama Physiologically active polypeptide-containing pharmaceutical composition
EP0601053B1 (en) 1991-08-26 2000-10-25 Abbott Laboratories Compositions and methods for the sublingual or buccal administration of therapeutic agents
AU666509B2 (en) 1991-12-24 1996-02-15 Yamanouchi Pharmaceutical Co., Ltd. Intrabuccally disintegrating preparation and production thereof
US5298256A (en) * 1992-04-28 1994-03-29 Corint, Ltd. Desmopressin buccal patch composition
US5534496A (en) * 1992-07-07 1996-07-09 University Of Southern California Methods and compositions to enhance epithelial drug transport
US5343672A (en) 1992-12-01 1994-09-06 Scherer Ltd R P Method for manufacturing freeze dried dosages in a multilaminate blister pack
CA2090738C (en) 1993-02-24 1996-05-21 Hema-Quebec Use of paf
SE9300937L (sv) * 1993-03-19 1994-09-20 Anne Fjellestad Paulsen Komposition för oral administrering av peptider
US5434121A (en) * 1993-03-25 1995-07-18 Mitsui Toatsu Chemicals, Incorporated Variety of Drechslera monoceras, weed control compositions containing the same as an effective ingredient and weed control methods using the same
SE501677C2 (sv) 1993-06-18 1995-04-10 Ferring Bv Biologiskt aktiva vasopressinanaloger, farmaceutiska preparat innehållande dem samt deras användning för framställning av läkemedel
US5500413A (en) * 1993-06-29 1996-03-19 Ferring Ab Process for manufacture of 1-deamino-8-D-arginine vasopressin
US5985835A (en) 1993-12-23 1999-11-16 Ferring B.V. Desmopressin for nocturia, incontinence and enuresis
US5482931A (en) 1993-06-29 1996-01-09 Ferring Ab Stabilized pharmaceutical peptide compositions
US5674850A (en) * 1993-12-23 1997-10-07 Ferring Ab High purity desmopressin produced in large single batches
ATE193892T1 (de) 1993-06-29 2000-06-15 Ferring Bv Synthese zyklischer peptide
ATE203412T1 (de) 1993-06-29 2001-08-15 Ferring Bv Zusammensetzungen zur nasalen verabreichung von desmopressin
CA2176927C (en) * 1993-11-17 2010-03-23 Seang H. Yiv Transparent liquid for encapsulated drug delivery
SE9400918L (sv) * 1994-03-18 1995-09-19 Anne Fjellstad Paulsen Stabiliserad komposition för oral administrering av peptider
FR2720003B1 (fr) * 1994-05-23 1998-06-26 Samsung Electro Mech Dispositif servant à inciser la peau pour une médication transcutanée.
DE4424800A1 (de) * 1994-07-14 1996-01-18 Philips Patentverwaltung Schaltungsanordnung zum Liefern von Speisespannungen
SE518619C2 (sv) * 1994-12-09 2002-10-29 Gs Dev Ab Komposition för reglerad frisättning innehållande monokaproin
GB9502879D0 (en) * 1995-02-14 1995-04-05 Oxford Biosciences Ltd Particle delivery
IL113459A (en) * 1995-04-23 2000-07-16 Electromagnetic Bracing System Electrophoretic cuff apparatus
US5843016A (en) 1996-03-18 1998-12-01 Physion S.R.L. Electromotive drug administration for treatment of acute urinary outflow obstruction
TW411277B (en) 1996-05-13 2000-11-11 Hisamitsu Pharmaceutical Co Percutaneous tape preparation containing fentanyl
GB9612629D0 (en) 1996-06-17 1996-08-21 Oxford Biosciences Ltd Method for providing dense particle compositions for use in transdermal particle delivery
DK0914178T3 (da) * 1996-06-18 2003-04-22 Alza Corp Anordning til forøgelse af transdermal afgivelse eller prøveudtagning af et middel
US5763398A (en) * 1996-06-20 1998-06-09 Ferring B.V. Nasal administration of desmopressin
US5922680A (en) * 1996-10-23 1999-07-13 Ferring, B.V. Stabilized composition for oral administration of peptides
SE9604341D0 (sv) 1996-11-26 1996-11-26 Ferring Bv Hepta-peptide oxytocin analogue
FR2758195B1 (fr) 1997-01-09 1999-02-26 Sgs Thomson Microelectronics Coprocesseur d'arithmetique modulaire comprenant deux circuits de multiplication operant en parallele
US5821230A (en) 1997-04-11 1998-10-13 Ferring Bv GnRH antagonist decapeptides
US6194407B1 (en) * 1997-07-30 2001-02-27 American Home Products Corporation Tricyclic pyrido vasopressin agonists
US5932745A (en) * 1997-07-30 1999-08-03 American Home Products Corporation Process for converting propargylic amine-N-oxides to enaminones
US6511974B1 (en) * 1997-07-30 2003-01-28 Wyeth Tricyclic vasopressin agonists
US5948433A (en) 1997-08-21 1999-09-07 Bertek, Inc. Transdermal patch
US7153845B2 (en) 1998-08-25 2006-12-26 Columbia Laboratories, Inc. Bioadhesive progressive hydration tablets
US20040018241A1 (en) * 1997-09-26 2004-01-29 Noven Pharmaceuticals, Inc. Bioadhesive compositions and methods for topical administration of active agents
US6322532B1 (en) 1998-06-24 2001-11-27 3M Innovative Properties Company Sonophoresis method and apparatus
US7138393B2 (en) * 1998-07-24 2006-11-21 Wyeth Biologically active vasopressin agonist metabolites
US6090803A (en) * 1998-07-24 2000-07-18 American Home Products Corporation Tricyclic vasopressin agonists
US6148232A (en) 1998-11-09 2000-11-14 Elecsys Ltd. Transdermal drug delivery and analyte extraction
GB9827292D0 (en) 1998-12-12 1999-02-03 Univ Strathclyde Freeze drying
US6406455B1 (en) 1998-12-18 2002-06-18 Biovalve Technologies, Inc. Injection devices
US20060025387A1 (en) * 1998-12-23 2006-02-02 Cytoscan Sciences Llc Compositions and methods for the treatment of disorders of the central and peripheral nervous systems
GB9901819D0 (en) 1999-01-27 1999-03-17 Scherer Corp R P Pharmaceutical compositions
US6344451B1 (en) * 1999-02-04 2002-02-05 American Home Products Pyrrolobenzodiazepine carboxyamide vasopressin agonists
US6297234B1 (en) 1999-02-04 2001-10-02 American Home Products Corporation Arylthiophene vasopressin agonists
US6235900B1 (en) * 1999-02-04 2001-05-22 American Home Products Corporation Tricyclic pyridine N-oxides vasopressin agonists
US6620807B1 (en) 1999-02-04 2003-09-16 Wyeth Pyridobenzodiazepine and pyridobenzoxazepine carboxyamide vasopressin agonists
CA2360102C (en) 1999-02-15 2009-05-19 Sumitomo Pharmaceuticals Co., Ltd. Tablets disintegrating rapidly in the oral cavity
WO2000048669A1 (en) 1999-02-18 2000-08-24 Biovalve Technologies, Inc. Electroactive pore
AR014640A1 (es) * 1999-02-23 2001-03-28 Univ Nac Quilmes UNA COMPOSICíoN FARMACÉUTICA INHIBIDORA DE LA DISEMINACIoN METASTÁSICA DURANTE LA CIRUGíA DE UN TUMOR CANCEROSO, UN PROCEDIMENTO DE PREPARACIoN Y UN KIT PARA UNA FORMULACIoN INYECTABLE.
US6248363B1 (en) * 1999-11-23 2001-06-19 Lipocine, Inc. Solid carriers for improved delivery of active ingredients in pharmaceutical compositions
US7060708B2 (en) * 1999-03-10 2006-06-13 New River Pharmaceuticals Inc. Active agent delivery systems and methods for protecting and administering active agents
US6210699B1 (en) 1999-04-01 2001-04-03 Watson Pharmaceuticals, Inc. Oral transmucosal delivery of drugs or any other ingredients via the inner buccal cavity
GB9908014D0 (en) 1999-04-08 1999-06-02 Scherer Corp R P Pharmaceutical compositions
US6720001B2 (en) * 1999-10-18 2004-04-13 Lipocine, Inc. Emulsion compositions for polyfunctional active ingredients
GB2355454A (en) 1999-10-20 2001-04-25 Ferring Bv Antidiuretic agents
US6558695B2 (en) * 1999-12-16 2003-05-06 Dermatrends, Inc. Topical and transdermal administration of peptidyl drugs using hydroxide releasing agents as permeation enhancers
GB0000079D0 (en) * 2000-01-05 2000-02-23 Ferring Bv Novel antidiuretic agents
DE60144229D1 (de) 2000-01-07 2011-04-28 Valeritas Inc Injektionsvorrichtung
US20070032410A1 (en) * 2000-01-11 2007-02-08 Atossa Healthcare, Inc. Compositions and methods for the treatment of psychiatric disorders
AT409081B (de) 2000-02-16 2002-05-27 Gebro Pharma Gmbh Stabile, nasal, oral oder sublingual anwendbare pharmazeutische zubereitung
GB0015601D0 (en) * 2000-06-26 2000-08-16 Ferring Bv Novel antidiuretic agents
TWI287984B (en) * 2000-10-17 2007-10-11 Wyeth Corp Pharmaceutical composition for modulating bladder function
EP1333880B1 (en) 2000-10-26 2009-04-15 Alza Corporation Transdermal drug delivery devices having coated microprotrusions
JP4434583B2 (ja) 2000-11-30 2010-03-17 バイオバルブ テクノロジーズ インコーポレイテッド 注射システム
AU2002241567A1 (en) * 2000-11-30 2002-07-24 Biovalve Technologies, Inc. Fluid delivery and measurement systems and methods
WO2002064193A2 (en) 2000-12-14 2002-08-22 Georgia Tech Research Corporation Microneedle devices and production thereof
WO2002050584A2 (en) * 2000-12-21 2002-06-27 Biovalve Technologies, Inc. Microneedle array systems
DE60220661T2 (de) 2001-03-16 2008-02-14 Alza Corp., Mountain View Transdermales pflaster zur verabreichung von fentanyl
US7022699B2 (en) * 2001-04-12 2006-04-04 Wyeth Cyclohexenyl phenyl diazepines vasopressin and oxytocin receptor modulators
CN1294134C (zh) * 2001-04-12 2007-01-10 惠氏公司 环己基苯基血管升压素激动剂
ES2282423T3 (es) * 2001-04-12 2007-10-16 Wyeth Azepinas y diazepinas bi- y triciclicas n-bifenilcarbonil- y n-fenilpiridilcarbonil sustituidas como agonistas de la vasopresina.
US7615234B2 (en) * 2001-09-11 2009-11-10 Glide Pharmaceutical Technologies Limited Drug delivery technology
IL160681A0 (en) 2001-09-13 2004-08-31 Kissei Pharmaceutical Crystals of hydroxynorephedrine derivatives
US6723077B2 (en) * 2001-09-28 2004-04-20 Hewlett-Packard Development Company, L.P. Cutaneous administration system
US6893655B2 (en) * 2001-10-09 2005-05-17 3M Innovative Properties Co. Transdermal delivery devices
MY148466A (en) 2001-10-26 2013-04-30 Merck Frosst Canada Ltd Granule formulation
BR0214224A (pt) * 2001-11-16 2004-09-21 Yamanouchi Pharma Co Ltd Derivado de 4,4-diflúor-1,2,3,4-tetrahidro-5h-1-benzazepina ou sal do mesmo
GB0210397D0 (en) 2002-05-07 2002-06-12 Ferring Bv Pharmaceutical formulations
HRP20041152B1 (hr) 2002-05-07 2008-01-31 Ferring B.V. Farmaceutske formulacije
US6945952B2 (en) * 2002-06-25 2005-09-20 Theraject, Inc. Solid solution perforator for drug delivery and other applications
GB2421689B (en) * 2002-08-05 2007-03-07 Caretek Medical Ltd Drug delivery system
EP1590033A2 (en) * 2002-09-30 2005-11-02 Alza Corporation Drug delivery device having coated microprojections incorporating vasoconstrictors
EP1555266B1 (en) * 2002-10-09 2014-05-21 Toray Industries, Inc. Remedies or preventives for urinary incontinence and morphinan derivatives having nitrogen-containing heterocyclic group
US7383084B2 (en) * 2002-10-31 2008-06-03 Transpharma Medical Ltd. Transdermal delivery system for dried particulate or lyophilized medications
EP1428526A1 (en) 2002-12-13 2004-06-16 Rijksuniversiteit Groningen Formulation for fast dissolution of lipophilic compounds
DE10259934B3 (de) * 2002-12-20 2004-10-14 H.C. Starck Gmbh Verfahren zur Herstellung von Formteilen aus Niob oder Tantal durch elektrochemisches Ätzen und so erhältliche Formteile
AR042815A1 (es) * 2002-12-26 2005-07-06 Alza Corp Dispositivo de suministro de agente activo que tiene miembros compuestos
MXPA05011521A (es) * 2003-04-28 2006-01-23 Astellas Pharma Inc Derivado de 4,4-difluoro-1,2,3,4-tetrahidro-5h-1-benzazepina o una sal del mismo.
US20060193825A1 (en) * 2003-04-29 2006-08-31 Praecis Phamaceuticals, Inc. Pharmaceutical formulations for sustained drug delivery
US7094545B2 (en) 2003-04-30 2006-08-22 Ferring Bv Pharmaceutical composition as solid dosage form and method for manufacturing thereof
DK1638468T3 (da) 2003-06-30 2007-12-17 Alza Corp Fremgangsmåde til coating af hudpiercingmikrofremspring
DK1500390T3 (da) * 2003-07-25 2005-09-19 Ferring Bv Farmaceutisk præparat som fast dosisform og fremgangsmåde til fremstilling deraf
CN1826099B (zh) 2003-07-25 2010-06-09 凡林有限公司 固体剂型药物组合物及其制造方法
US6930932B2 (en) * 2003-08-27 2005-08-16 Hewlett-Packard Development Company, L.P. Data signal reception latch control using clock aligned relative to strobe signal
CA2543086A1 (en) * 2003-10-24 2005-05-12 Alza Corporation Pretreatment method and system for enhancing transdermal drug delivery
CA2543084A1 (en) * 2003-10-24 2005-05-12 Alza Corporation Apparatus and method for enhancing transdermal drug delivery
KR20060099523A (ko) * 2003-10-31 2006-09-19 알자 코포레이션 미세 돌출부 어레이를 위한 자가 작동 어플리케이터
WO2005046707A1 (en) 2003-11-10 2005-05-26 Fein Seymour H Pharmaceutical compositions including low dosages of desmopressin
ES2260563T3 (es) * 2003-11-13 2006-11-01 Ferring B.V. Paquete de blister y forma farmaceutica solida para ello.
US7018653B2 (en) * 2003-12-29 2006-03-28 Ferring B.V. Method for preparing solid dosage form of desmopressin
ATE319430T1 (de) 2003-12-29 2006-03-15 Ferring Bv Verfahren zur herstellung einer festen oralen dosierungsform von desmopressin
WO2005069758A2 (en) * 2004-01-09 2005-08-04 Alza Corporation Frequency assisted transdermal agent delivery method and system
PL1797109T3 (pl) * 2004-09-09 2016-11-30 Mieszaniny polipeptydów, kompozycje zawierające je i procesy ich wytwarzania oraz ich zastosowania
US7097776B2 (en) * 2004-10-22 2006-08-29 Hewlett-Packard Development Company, L.P. Method of fabricating microneedles
US20060093658A1 (en) * 2004-10-26 2006-05-04 Gayatri Sathyan Apparatus and method for transdermal delivery of desmopressin
CN100339081C (zh) 2004-11-10 2007-09-26 范敏华 一种氯雷他定口腔崩解片剂的制备方法
US7180274B2 (en) * 2004-12-10 2007-02-20 Aimtron Technology Corp. Switching voltage regulator operating without a discontinuous mode
US20060241172A1 (en) 2005-04-22 2006-10-26 Wyeth Benzodioxane and benzodioxolane derivatives and uses thereof
TW200718692A (en) 2005-04-22 2007-05-16 Wyeth Corp Dihydrobenzofuran derivatives and uses thereof
US7856263B2 (en) 2005-04-22 2010-12-21 Travanti Pharma Inc. Transdermal systems for the delivery of therapeutic agents including granisetron using iontophoresis
GT200600166A (es) 2005-04-22 2007-03-14 Derivados de cromano y cromeno y usos de los mismos
AU2006239942A1 (en) 2005-04-22 2006-11-02 Wyeth Dihydrobenzofuran derivatives and uses thereof
WO2006116151A1 (en) 2005-04-22 2006-11-02 Wyeth Benzofuranyl alkanamine derivatives and uses thereof as 5-ht2c agonists
TW200716106A (en) 2005-04-24 2007-05-01 Wyeth Corp Methods for modulating bladder function
US20080213461A1 (en) 2005-06-17 2008-09-04 Georgia Tech Research Corporation Coated Microstructures and Methods of Manufacture Thereof
EP1904158B1 (en) 2005-06-24 2013-07-24 3M Innovative Properties Company Collapsible patch with microneedle array
WO2007083323A2 (en) 2006-01-23 2007-07-26 Panacea Biotec Limited. Modified release oral dosage form comprising desmopressin
CA2584456C (en) 2006-03-02 2008-07-22 Ferring International Center S.A. Composition comprising desmopressin
US8101114B2 (en) 2006-05-01 2012-01-24 Georgia Tech Research Corporation Particle based molding
KR101522747B1 (ko) * 2007-08-06 2015-05-26 알레간 인코포레이티드 데스모프레신 약물 전달을 위한 방법 및 장치
NO3085381T3 (enExample) * 2008-05-21 2018-09-15

Cited By (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2016196514A (ja) * 2008-05-21 2016-11-24 フエリング・インターナシヨナル・センター・エス・アー 夜間頻尿によって妨げられない睡眠の初期期間を増加させるための口腔内崩壊デスモプレシン
JP2018035198A (ja) * 2008-05-21 2018-03-08 フエリング・インターナシヨナル・センター・エス・アー 夜間頻尿によって妨げられない睡眠の初期期間を増加させるための口腔内崩壊デスモプレシン
JP2019123739A (ja) * 2008-05-21 2019-07-25 フエリング・インターナシヨナル・センター・エス・アー 夜間頻尿によって妨げられない睡眠の初期期間を増加させるための口腔内崩壊デスモプレシン

Also Published As

Publication number Publication date
DK2296686T3 (da) 2014-05-12
JP2016196514A (ja) 2016-11-24
EP3225249B1 (en) 2018-11-07
HRP20161066T1 (hr) 2016-10-21
DK3085381T3 (en) 2018-05-28
ES2677548T3 (es) 2018-08-03
SI3085381T1 (en) 2018-06-29
JP2018035198A (ja) 2018-03-08
HUE046050T2 (hu) 2020-01-28
ES2462465T3 (es) 2014-05-22
LUC00015I1 (enExample) 2017-04-19
US9974826B2 (en) 2018-05-22
DK2712622T3 (en) 2016-09-12
JP6506821B2 (ja) 2019-04-24
NO3085381T3 (enExample) 2018-09-15
LT3225250T (lt) 2019-11-11
EP2296686B2 (en) 2017-11-01
NO2019021I1 (no) 2019-04-30
TR201807224T4 (tr) 2018-06-21
PL3225249T3 (pl) 2019-05-31
PL3225250T3 (pl) 2020-02-28
PL3085381T3 (pl) 2018-09-28
SI3225250T1 (sl) 2019-11-29
LT2712622T (lt) 2016-09-26
JP6001121B2 (ja) 2016-10-05
LT3225249T (lt) 2019-01-10
SI2712622T1 (sl) 2016-10-28
CA2724653A1 (en) 2009-11-26
HUS1900024I1 (hu) 2019-05-28
EP2712622B1 (en) 2016-07-13
PT3225250T (pt) 2019-10-15
EP3085381A1 (en) 2016-10-26
PT2296686E (pt) 2014-05-23
HRP20180774T1 (hr) 2018-08-10
JP2019123739A (ja) 2019-07-25
ES2596435T3 (es) 2017-01-09
HUE039013T4 (hu) 2019-08-28
ES2710454T3 (es) 2019-04-25
DK2296686T4 (en) 2018-01-02
PT3085381T (pt) 2018-05-18
EP3225250A1 (en) 2017-10-04
EP2296686B1 (en) 2014-02-12
EP2712622A1 (en) 2014-04-02
PT3225249T (pt) 2019-01-17
HUE041370T2 (hu) 2019-05-28
US20090291880A1 (en) 2009-11-26
HRP20191854T1 (hr) 2019-12-27
DK3225250T3 (da) 2019-11-04
JP6836618B2 (ja) 2021-03-03
HRP20190114T1 (hr) 2019-03-08
EP3085381B1 (en) 2018-04-18
SI3225249T1 (sl) 2019-02-28
TR201819189T4 (tr) 2019-01-21
LUC00015I2 (enExample) 2017-06-19
ES2756706T3 (es) 2020-04-27
JP6258424B2 (ja) 2018-01-10
EP2296686A1 (en) 2011-03-23
WO2009143356A1 (en) 2009-11-26
PL2712622T3 (pl) 2017-01-31
EP3225250B1 (en) 2019-08-21
EP3225249A1 (en) 2017-10-04
PL2296686T5 (pl) 2018-06-29
PL2296686T3 (pl) 2014-07-31
US20180250357A1 (en) 2018-09-06
LTPA2017001I1 (lt) 2017-02-10
PT2712622T (pt) 2016-10-13
JP2015120761A (ja) 2015-07-02
HUE030409T2 (en) 2017-05-29
JP2011520980A (ja) 2011-07-21
NO2296686T3 (enExample) 2014-07-12
ES2462465T5 (es) 2018-02-28
LT3085381T (lt) 2018-06-11
HUE039013T2 (hu) 2018-12-28
LTC2712622I2 (lt) 2020-02-10
DK3225249T3 (en) 2019-02-25

Similar Documents

Publication Publication Date Title
JP6258424B2 (ja) 夜間頻尿によって妨げられない睡眠の初期期間を増加させるための口腔内崩壊デスモプレシン
JP6297616B2 (ja) 夜間排尿数を低減するためのデスモプレシン
US11963995B2 (en) Methods comprising desmopressin
HK40002265A (en) Desmopressin for reducing nocturnal voids
HK1238572B (en) Orodispersible desmopressin for increasing initial period of sleep undisturbed by nocturia
HK1196253A (en) Orodispersible desmopressin for increasing initial period of sleep undisturbed by nocturia
HK1228266B (en) Orodispersible desmopressin for increasing initial period of sleep undisturbed by nocturia
HK1196253B (en) Orodispersible desmopressin for increasing initial period of sleep undisturbed by nocturia
HK1216298B (en) Desmopressin for reducing nocturnal voids

Legal Events

Date Code Title Description
A521 Request for written amendment filed

Free format text: JAPANESE INTERMEDIATE CODE: A821

Effective date: 20110125

RD03 Notification of appointment of power of attorney

Free format text: JAPANESE INTERMEDIATE CODE: A7423

Effective date: 20110125

RD04 Notification of resignation of power of attorney

Free format text: JAPANESE INTERMEDIATE CODE: A7424

Effective date: 20110127

A521 Request for written amendment filed

Free format text: JAPANESE INTERMEDIATE CODE: A523

Effective date: 20120521

A621 Written request for application examination

Free format text: JAPANESE INTERMEDIATE CODE: A621

Effective date: 20120521

A521 Request for written amendment filed

Free format text: JAPANESE INTERMEDIATE CODE: A523

Effective date: 20120823

A131 Notification of reasons for refusal

Free format text: JAPANESE INTERMEDIATE CODE: A131

Effective date: 20130911

A601 Written request for extension of time

Free format text: JAPANESE INTERMEDIATE CODE: A601

Effective date: 20131204

A602 Written permission of extension of time

Free format text: JAPANESE INTERMEDIATE CODE: A602

Effective date: 20131211

A02 Decision of refusal

Free format text: JAPANESE INTERMEDIATE CODE: A02

Effective date: 20141201

A521 Request for written amendment filed

Free format text: JAPANESE INTERMEDIATE CODE: A523

Effective date: 20150331

A911 Transfer to examiner for re-examination before appeal (zenchi)

Free format text: JAPANESE INTERMEDIATE CODE: A911

Effective date: 20150413

TRDD Decision of grant or rejection written
A01 Written decision to grant a patent or to grant a registration (utility model)

Free format text: JAPANESE INTERMEDIATE CODE: A01

Effective date: 20150520

A61 First payment of annual fees (during grant procedure)

Free format text: JAPANESE INTERMEDIATE CODE: A61

Effective date: 20150618

R150 Certificate of patent or registration of utility model

Ref document number: 5767103

Country of ref document: JP

Free format text: JAPANESE INTERMEDIATE CODE: R150

R250 Receipt of annual fees

Free format text: JAPANESE INTERMEDIATE CODE: R250

R250 Receipt of annual fees

Free format text: JAPANESE INTERMEDIATE CODE: R250

R250 Receipt of annual fees

Free format text: JAPANESE INTERMEDIATE CODE: R250

R250 Receipt of annual fees

Free format text: JAPANESE INTERMEDIATE CODE: R250

R250 Receipt of annual fees

Free format text: JAPANESE INTERMEDIATE CODE: R250

R250 Receipt of annual fees

Free format text: JAPANESE INTERMEDIATE CODE: R250

R250 Receipt of annual fees

Free format text: JAPANESE INTERMEDIATE CODE: R250

R250 Receipt of annual fees

Free format text: JAPANESE INTERMEDIATE CODE: R250